Muna Launches On 'Rising Tide' Of Alzheimer's
Raises $73m In Series A Financing
Backed by investors such as Sofinnova, Polaris and Sanofi Ventures, Muna has assembled a strong team dedicated to developing small molecules to repair neuronal dysfunction and resolve neuroinflammation.
